Dedicated specialist project managers and experienced clinical development professionals to deliver services from consultative design and data collection through robust reporting.

We focus on providing specific services designed to support products from the point of approval / marketing authorization through launch and beyond.

We provide phase IIIb and IV, post marketing, non-interventional, observational, epidemiology, compliance, investigator-initiated trials and registry services.

Trialink has also a large expertise in the implementation of Risk Based Monitoring (RBM) according to the current guidelines (FDA, EMEA, TransCelerate,…).